Trademark: 88130621
Status Date
Monday, December 5, 2022
Filing Date
Tuesday, September 25, 2018
Published for Opposition
Tuesday, September 3, 2019
Abandoned Date
Monday, December 5, 2022
5 Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
42 Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
Dec 5, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 5, 2022
Abandonment - No Use Statement Filed
Jul 15, 2022
Assigned To Examiner
May 2, 2022
Assigned To Examiner
Apr 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 25, 2022
Sou Extension 5 Granted
Apr 20, 2022
Sou Extension 5 Filed
Apr 25, 2022
Case Assigned To Intent To Use Paralegal
Apr 20, 2022
Teas Extension Received
Apr 15, 2022
Teas Change Of Correspondence Received
Apr 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 8, 2021
Sou Extension 4 Granted
Oct 8, 2021
Sou Extension 4 Filed
Oct 8, 2021
Teas Extension Received
Apr 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2021
Sou Extension 3 Granted
Apr 15, 2021
Sou Extension 3 Filed
Apr 15, 2021
Teas Extension Received
Jan 13, 2021
Automatic Update Of Assignment Of Ownership
Sep 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 25, 2020
Sou Extension 2 Granted
Sep 25, 2020
Sou Extension 2 Filed
Sep 25, 2020
Teas Extension Received
Aug 13, 2020
Teas Change Of Correspondence Received
Aug 13, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 13, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 3, 2020
Sou Extension 1 Granted
Apr 3, 2020
Sou Extension 1 Filed
Apr 3, 2020
Teas Extension Received
Nov 12, 2019
Assigned To Examiner
Oct 29, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 3, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 3, 2019
Published For Opposition
Aug 14, 2019
Notification Of Notice Of Publication E-Mailed
Jul 31, 2019
Assigned To Lie
Jul 24, 2019
Approved For Pub - Principal Register
Jul 4, 2019
Teas/Email Correspondence Entered
Jul 3, 2019
Correspondence Received In Law Office
Jul 3, 2019
Teas Response To Office Action Received
Jan 8, 2019
Notification Of Non-Final Action E-Mailed
Jan 8, 2019
Non-Final Action E-Mailed
Jan 8, 2019
Non-Final Action Written
Jan 7, 2019
Assigned To Examiner
Oct 2, 2018
New Application Office Supplied Data Entered In Tram
Sep 28, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
